We have a suspicion that you are an automated web bot software, not a real user. To keep our site fast for other users, we have slowed down this page. The slowdown will gradually disappear. If you think this is a mistake, please contact us at genome-www@soe.ucsc.edu. Also note that all data for hgGeneGraph can be obtained through our public MySQL server and all our software source code is available and can be installed locally onto your own computer. If you are unsure how to use these resources, do not hesitate to contact us.
UCSC Genome Browser Gene Interaction Graph
Gene interactions and pathways from curated databases and text-mining

◀ Back to IL13

IL13 — INS

Text-mined interactions from Literome

Mabley et al., Br J Pharmacol 2001 (Diabetes Mellitus, Experimental) : In vitro the cytokine combination ; interleukin-1beta , tumor necrosis factor-alpha and interferon-gamma inhibited glucose stimulated insulin secretion from isolated rat islets of Langerhans and decreased RIN-5F cell viability
Rabinovitch et al., Diabetologia 1992 : The individual cytokines, interleukin 1 ( 1 U/ml ), tumour necrosis factor ( 10 ( 2 ) U/ml ), and interferon gamma ( 10 ( 2 ) U/ml ) inhibited insulin release but did not increase islet malondialdehyde levels
Fain et al., Metabolism 2005 : Insulin enhances vascular endothelial growth factor, interleukin-8 , and plasminogen activator inhibitor 1 but not interleukin-6 release by human adipocytes
Yelich et al., Pancreas 1992 : Effects of endotoxin and interleukin-1 on glucagon and insulin secretion from the perfused rat pancreas
Zawalich et al., Mol Cell Endocrinol 1991 : Influence of staurosporine, nitrendipine and monooleoylglycerol on interleukin-1 induced insulin secretion and phosphoinositide hydrolysis
Johannesen et al., Acta Endocrinol (Copenh) 1990 : During beta-cell stimulation with tolbutamide, interleukin 1 beta caused inhibition of insulin accumulation to 36 +/- 9 % of control
Shimizu et al., J Endocrinol Invest 1991 : Involvement of interleukin-1 in the inhibition of in vivo insulin release : possible role of adrenal glands
Uehara et al., Eur J Pharmacol 1991 (Hyperinsulinism) : With the aim of studying the mechanism by which peripherally injected interleukin-1 increases the serum levels of insulin in conscious rats, the effects of indomethacin, a cyclooxygenase inhibitor, on interleukin-1 induced hyperinsulinemia were examined using male Wistar rats implanted with intra-atrial cannulas ... It was also found that this insulin response to interleukin-1 was dose related ... Pretreatment with indomethacin ( 3 mg/kg body weight ), however, completely blocked the interleukin-1 induced stimulation of insulin secretion
Parazzoli et al., J Biol Chem 2012 : Cyclooxygenase-2, not microsomal prostaglandin E synthase-1, is the mechanism for interleukin-1ß induced prostaglandin E2 production and inhibition of insulin secretion in pancreatic islets
Helqvist et al., Acta Endocrinol (Copenh) 1989 : Treatment with 10 mumol/l of verapamil ( a potent blocker of the voltage dependent calcium channel ) tended to suppress the inhibitory effect of interleukin 1 on insulin release from rat islets, suggesting protection against cytotoxicity
Hansen et al., Biomed Biochim Acta 1988 : Effect of interleukin-1 on the biosynthesis of proinsulin and insulin in isolated rat pancreatic islets
Sandler et al., Endocrinology 1987 : Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets
Rabinovitch et al., Diabetologia 1994 : The individual cytokines, interleukin 1 ( 10 U/ml ), tumour recrosis factor ( 10 ( 3 ) U/ml ) and interferon gamma ( 10 ( 3 ) U/ml ) inhibited insulin release from rat islets, but did not cause DNA fragmentation or destroy islet cells ; by contrast, combination of the three cytokines induced DNA fragmentation and islet-cell death